Cancer (Oncology)

Oncology Review: A positive trajectory for approvals

Read more

Oncology drug approvals rise, with help from China

Read more

Checkpoint Inhibitors: A decade of innovation

Read more

ESMO 2021: Oncology developers present their findings

Read more

Live biotherapeutics change the pharma landscape

Read more

ASCO 2021- Oncology developers disclose their latest data

Read more

Oncology approvals rise, driven by novel compounds

Read more

Hot targets in immuno-oncology

Read more

The Bispecific Approach, Interviews with Merus, Genmab and NovalGen

Read more

Why we should take a second look at RNA therapeutics

Read more